Jylamvo, an Oral Solution Formulation of Methotrexate, Is Now Available
Jylamvo, an oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana.
Source: cancertherapyadvisor.com
Page 20 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
Jylamvo, an FDA-Approved Oral Solution Formulation of Methotrexate, Now Available
Jylamvo, an FDA-approved oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana.
Source: empr.com
Empowering Advanced Practice Providers to Adopt Routine Screening for Tardive Dyskinesia
Tardive dyskinesia (TD) is an involuntary movement disorder associated with prolonged use of dopamine receptor blocking agents (DRBAs) that can range in severity and presentation and can impact social, emotional, and functional components of daily life. There are treatments that can effectively manage TD, but first it needs to be recognized and accurately diagnosed.
Source: psychiatrictimes.com
Alyglo Approved for Patients With Primary Humoral Immunodeficiency
The FDA has approved Alyglo (immune globulin intravenous, human-stwk) 10% liquid to treat primary humoral immunodeficiency in adults.
Source: empr.com
Managing Mental Health and Tardive Dyskinesia During the Holiday Season
(BPT) - Moira manages her depression and tardive dyskinesia and is supported by her husband and care partner Forrest.
Source: romesentinel.com